Skip to main content
OpenTrials
Completed

NCT Number: NCT01979887

Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction

This is an exploratory study to evaluate endpoints used to characterize participants with and without meibomian gland dysfunction (MGD) and will evaluate the correlation between signs and symptoms of MGD. No investigational drug will be administered in this study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

London, United Kingdom

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Participants characterized as with or without Meibomian Gland Dysfunction.

Exclusion criteria

  • Lid heating therapy, therapeutic gland expression, or meibomian gland probing within 12 months of enrollment
  • Contact lens use in the 30 days prior to enrollment
  • Lid hygiene within 48 hours prior to enrollment
  • Use of eye makeup within 8 hours of enrollment
  • Eyelash growth-stimulating products within 30 days prior to enrollment
  • Use of systemic vitamins and/or systemic supplements containing omega 3 fatty acids within 60 days of enrollment
  • Use of systemic anti-histamines within 30 days prior to enrollment.

Treatment and study plan

Meibum Expression

Procedure

Meibum expression as per protocol. No investigational drug is administered in this study.

Primary outcomes

  1. Meibum Quality Score in the Study Eye as Assessed by the Investigator Using a 4-Point Scale

    Time frame: Day 22

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Nov 8, 2013
Registry last updated
Aug 15, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.